Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma

British Journal of Cancer

Volumn 82, Issue 1, 2000, Pages 20-27

  Durany, N ^a   Joseph, J ^a   Jimenez, O M ^a   Climent, F ^a   Fernandez P L ^b   Rivera, F ^b   Carreras, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

2,3 Bisphosphoglycerate phosphatase; Breast carcinoma; Creatine kinase; Enolase; Phosphoglycerate mutase activity and isoenzymes

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; CREATINE KINASE; CREATINE KINASE BB; ENOLASE; ESTROGEN RECEPTOR; ISOENZYME; PHOSPHATASE; PHOSPHOGLYCERATE MUTASE; PROGESTERONE RECEPTOR;

ARTICLE; BREAST; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0033986792     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0871     Document Type: Article

References (74)

1. Bais R and Edwards J (1982) Creatine kinase. Crit Rev Clin Lab Sci 16: 291-335
2. Bartrons R and Carreras J (1982) Purification and characterzation of phosphoglycerate mutase isoenzymes from pig heart. Biochim Biophys Acta 708: 167-177
3. Bradford M (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
4. Carreras J and Gallego C (1993) Metabolism of 2,3-bisphosphoglyceric acid in erythroid cells and tissues of vertebrates. Trends Comp Biochem Physiol 1: 421-450
5. Carreras J, Bartrons R, Climent F and Cussó R (1986) Bisphosphorylated metabolites of glycerate, glucose and fructose: functions, metabolism and molecular patholgy. Clin Biochem 19: 348-358
6. Chastain S, Ketchum C and Grizzle W (1988) Stability and electrophoretic characteristics of creatine kinase BB extracted from human brain and intestine. Clin Chem 334: 489-492
7. Crabtree B, Leech A and Newsholme A (1979) Measurement of enzyme activities in crude extracts of tissues. In: Techniques in the Live Sciences, Vol B2/1, Kornberg HL, Metcalfe JC, Northcote DH, Pogson CI and Tipton KF (eds), pp. B211/1-B211/37. Elservier/North Holland Biomedical Press: Amsterdam
8. Desjardins P (1982) Characterization of an atypical creatine kinase from human heart tissue, with properties similar to those of mitochondrial crealine kinase. Clin Chim Acta 121: 67-78
9. Durany N and Carreras J (1996) Distribution of phosphoglycerate mutase isozymes in rat, rabbit and human tissues. Comp Biochem Physiol 113: 217-223
10. Durany N, Joseph J, Campo E, Molina R and Carreras J (1997a) Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas. Br J Cancer 76: 969-977
11. Durany N, Joseph J, Cruz-Sanchez F and Carreras J (1997b) Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and creatine kinase activity and isoenzymes in human brain tumours. Br J Cancer 76: 1139-1149
12. Frikstein B, Nesland J, Otlestad L, Lund E, Johannessen J (1988) Neuron-specific enolase-positive breast carcinomas. Histol Histophatol 3: 97-102
13. Foreback C and Chu J (1981) Creatine kinase isoenzymes: electrophoretic and quantitative measurements. Crit Rev Clin Lab Sci 15: 187-230
14. Fothergill-Gilmore L and Watson H (1989) The phosphoglycerate mutases. Adv Enzymol 62: 227-313
15. Gerbitz K, Summer J and Schumacher I (1986) Enolase isoenzymes as tumour markers. J Clin Chem Clin Biochem 24; 1009-1016
16. Griffiths J (1982) Creatine kinase isoenzyme L Clin Lab Med 2: 493-506
17. Haimoto J, Takahashi Y, Koshikawa T, Nagura H and Kato K (1985) Immunohistochemical localization of γ-enolase in normal human tissues other than nervous and neuroendocrine tissues. Lab Invest 52: 257-263
18. Hennipman A, Smits J, Van Oirschot B, Van Houwelingen J, Rijksen G, Neyt J, Van Unnik J and Staal G (1987) Glycolitic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumor Biol 8: 251-263
19. Hennipman A, Van Oirschot B, Smits J, Rijksen G and Staal G (1988) Heterogeneity of glycolytic enzyme activity and isozyme composition of pyruvate kinase in breast cancer. Tumor Biol 9: 178-189
20. Ingelman-Sundberg H, Wikström B, Stormby N, Sundelin P and Hjerpe A (1989) Immunocytochemical reactivity of breast cancer tissue with antibodies to neuron-specific enolase and an adenocarcinoma-associated glycolipid antigen. Virchows Archiv A Pathol Anat 415: 539-544
21. Jares P, Rey M, Fernández P, Campo E, Nadal A, Muñoz M, Mallofré C, Muntané J, Nayach I, Estapé J and Cardesa A (1997) Cyclin D1 and retinoblasloma gene expression in human breast carcinoma: correlation with tumor proliferation and estrogen receptor status. J Pathol 182: 160-166
22. Joseph J, Cardesa A and Carreras J (1997) Creatine kinase activity and isoenzymes in lung, colon and liver carcinomas. Br J Cancer 76: 100-105
23. Joseph J, Cruz-Sánchez F and Carreras J (1996) Enolase activity and isoenzyme distribution in human brain regions and tumors. J Neurochem 66: 2484-2490
24. Kaiser E, Kuzmits R, Pregant P, Burghuber O and Worofka W (1989) Clinical biochemistry of neuron specific enolase. Clin Chim Acta 183: 13-32
25. Kanemitsu F and Okigaki T (1988) Creatine kinase: a review. J Cromatog 429: 399-417
26. Kato K, Ishiguro Y und Ariyoshi Y (1983) Enolase isozymes as disease markers: distribution of three enolase subunits (α. β and γ) in various human tissues. Disease Markers 1: 213-220
27. Kaye A (1983) Enzyme induction by strogen. J Steroid Biochem 19: 33-40
28. Kaye A, Reiss N, Shaer A, Sluyser M, Iacobelli S, Amroch D and Soffer Y (1981) Estrogen responsive creatine kinase in normal and neoplastic cells. J Steroid Biochem 15: 69-75
29. Kaye A, Hallowes R, Cox S and Sluyser M (1986) Hormone-responsive creatine kinase in normal and neoplastic mammary glands. Ann NY Acad Sci 464: 218-230
30. Klein B and Jennelot C (1978) Anion-exchange chromatography of erythrocytic and muscle adenylate kinase and its effect on the serum creatine kinase isoenzyme assays. Clin Chem 24: 2168-2170
31. Klinga K, Kaufman M, Runnebaum B and Kubli F (1982) Distribution of estrogen and progesterone receptors in primary tumor and lymphnodes in individual patients with breast cancer. Oncology 39: 337-339
32. Lakatua D and Mohammed R (1986) Estrogen and progesterone receptors and creatine kinase isoenzymes in human breast cancer. Clin Chem 32: 2103-2104
33. Lilleng R, Hagmar B and Nesland J (1992) C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast. Mod Palhol 5: 41-17
34. Lindsey G and Diamond E (1978) Evidence for significant quantities of creatine kinase MM isoenzyme in human brain. Biochim Biophys Acta 524: 78-84
35. McCarly K Jr. Miller L, Cox E, Konrath J and McCarty K (1985) Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109: 716-722
36. Marangos P and Schmechel D (1987) Neuron specific enolase, a clinically useful marker for neurons and nonendocrine cells. Annu Rev Neurosci 10: 269-295
37. Matsushima S, Mori M, Adachi Y, Matsukuma A and Sugimachi K (1994) S100 protein positive human breast carcinomas: an immunohistochemical study. J Surg Oncol 55: 108-113
38. Messeri G, Tozzi P, Boddi V and Ciatto S (1983) Glucose-6-phosphate dehydrogenase activity and estrogen receptors in human breast cancer. J Steroid Biochem 19: 1647-1650
39. Meyer I, Thompson J, Kiser E and Haven G (1980) Observation of a variant creatine kinase isoenzyme in sera and breast tumor cytosols. Am J Clin Pathol 74: 332-336
40. Nanji A (1983) Serum creatine kinase isoenzymes: a review. Muscle Nerve 6: 83-90
41. Nesland J, Memoli V, Holm R, Gould V and Johannessen J (1985) Breast carcinomas with neuroendocrine differentiation. Ultrastruct Pathol 8: 225-240
42. Nesland J, Holm R and Johannessen J (1986a) A study of different markers for neuroendocrine differentiation in breast carcinomas. Path Res Pract 181: 524-530
43. Nesland J, Holm R, Johannessen J and Gould V (1986b) Neurone-specific enolase immunostaining in the diagnosis of breast carcinomas with neuroendocrine differentiation. Its usefulness and limitations. J Pathol 148: 35-43
44. Nesland J, Lundi S, Holm R and Johannessen J (1987) Electron microscopy and immunostaining of the normal breast and its benign lesions: a search for neuroendocrine cells. Histol Histopath 2: 73-77
45. Nesland J, Holm R, Johannessen J and Gould V (1988) Neuroendocrine differentiation in breast lesions. Path Res Pract 183: 214-221
46. Nesland J, Ottestad L, Heikilla R, Holm R, Tveit K and Borresen A-L (1991a) C-erbB-2 protein and neuroendocrine expression in breast carcinomas. Anticancer Res 11: 161-168
47. Nesland J, Ottestad L, Borresen A-L, Tvedt K, Holm R, Heikkilà R and Tveit K (1991b) The c-erbB-2 protein in primary and metastatic breast carcinomas. Ultrastruct Pathol 15: 281-289
48. Omenn G and Cheung C-Y (1974) Phosphoglycerate mutase isozyme marker for tissue differentiation in man. Am J Hum Genet 26: 393-399
49. Omenn G and Hermodson M (1975) Human phosphoglycerate mutase: isozyme marker for muscle differentiation and for neoplasia. In Isozymes Vol. 3 (Markert C1 ed) pp. 1005-1019. Academic Press: New York
50. Osborne K (1985) Heterogeneity in hormone receptor status in primary and metastatic breast cancer. Semin Oncol 12: 317-326
51. Pahlman S, Esscher T and Nilsson K (1986) Expression of γ-subunit of enolase, neuron-specific enolase, in human non-neuroendocrine tumors and derived cell lines. Lab Invest 54: 554-560
52. Pertschuk L, Eisenberg K and Carter A (1985) Heterogeneity of estrogen binding sites in breast cancer: morphologic demonstration and relationship to endocrine response. Breast Cancer Res Treat 5: 137-147
53. Rapoport S (1968) The regulation of glycolysis in mammalian erythrocytes. Essays Biochem 4: 69-103
54. Reeve J, Stewart J, Watson D, Wulfrank D, Twentyman P and Bleehen N (1986) Neuron specific enolase expression in carcinoma of the lung. Br J Cancer 53: 519-528
55. Royds J, Taylor C and Timperley W (1985) Enolase isoenzymes as diagnostic markers. Neophatol Appl Neurobiol 11: 1-16
56. Scambia G, Natoli V, Panici P, Sica G and Mancuso S (1986a) J Cancer Res Clin Oncol 112: 29-32
57. Scambia G, Panici P, Sica G, Natoli V, Caruso A and Mancuso S (1986b) Creatine kinase activity and steroidal hormone receptors in primary breast cancer. Ann N Y Acad Sci 464: 511-513
58. Scambia G, Santeunasio G, Panici P, Iacobelli S and Mancuso S (1988) Immunochemical localization of creatine kinase BB in primary breast cancer: correlation with estrogen receptor content. J Cancer Res Clin Oncol 114: 101-104
59. Schmechel D (1985) γ-Subunit of the glycolitic enzyme enolase: nonspecific or neuron specific? Lab Invest 52: 239-242
60. Schmechel D, Marangos P and Brightman M (1978) Neuron-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 276: 834-836
61. Scopsi L, Andreola S, Pilotti S, Testori A, Baldini M, Leoni F, Lombardi L, Hutton J, Shimizu F, Rosa P et al (1992) Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parameters. Am J Surg Pathol 16: 561-576
62. Taylor C, Royds J, Parsons M and Timperley W (1983) Diagnostic aspects of enolase isozymes. Curr Topics Biol Med Res 11. 95-110
63. Tsung A (1983) Creatine kinase activity and isoenzyme pattern in various normal tissues and neoplasms. Clin Chem 29: 2040-2043
64. Urdal P, Urdal K and Stromme J (1983) Cytoplasmic creatine kinase isoenzymes quantitated in tissue specimens obtained at surgery. Clin Chem 29: 310-313
65. Vinores S, Bonnin J, Rubinstein L and Marangos P (1984) Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues. Arch Pathol Lab Med 108: 536-539
66. Wallimann T, Wyss M, Bridiczka D, Nicolay K and Eppenberger M (1992) Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostais. Biochem J 281: 21-40
67. Wilander E, Phalman S, Sällström J and Lindgrem A (1987) Neuron-specific enolase expression and neuroendocrine differentiation in carcinomas of the breast. Arch Pathol Lab Med 111: 830-832.
68. Winstend S and Hopps J (1985) Enzyme studies in breast tumor cytosols. Clin Chem 31: 986
69. Wold F (1971) Enolase. In: The Enzymes, Vol V, Boyer P D (ed). pp. 499-538. Academic Press: New York
70. Wold L, Chin-Yang L and Homburger H (1981) Localization of the B and M polypeptide subunits of creatine kinase in normal and neoplastic human tissues by an immunoperoxidase technic. Am J Clin Pathol 75: 327-332
71. Wyss M, Smeitink J, Wevers R and Wallimann T (1992) Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochim Biophys Acta 1102: 119-166
72. Zarghami N, Yu H, Diamandis E and Sutherland D (1995) Quantification of creatine kinase BB isoenzyme in tumor cytosols and serum with an ultrasensitive time-resolved immunofluorometric technique. Clin Biochem 28: 243-253
73. Zarghami N, Giai M, Yu H, Roagna R, Ponzone R, Katsaros D, Sismondi P and Diamandis E (1996) Ceratine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients. Br J Cancer 73: 386-390
74. Zeltzer P, Schneider S, Marangos P and Zweig M (1986) Differential expression of neural isozymes by human medulloblastomas and gliomas and neuroectodermal cell lines. J Natl Cancer Inst 77: 625-631.